A European perspective on depression in the community: The DEPRES study

CNS Spectrums

Volumn 7, Issue 2, 2002, Pages 120-126

  Arbabzadeh Bouchez, Saena ^a   Tylee, Andre ^b   Lépine, Jean Pierre ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; CLUSTER ANALYSIS; CONSULTATION; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; EMPLOYMENT; EUROPE; HEALTH CARE UTILIZATION; HEALTH PRACTITIONER; HUMAN; MEDICAL ASSESSMENT; PATIENT CARE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL DISABILITY; SYMPTOM;

EID: 0036069453     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900017430     Document Type: Review

References (22)

1. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study
2. The Zurich study. III. Diagnosis of depression
3. Lifetime prevalence of psychiatric disorders in Edmonton
4. The prevalence of specific psychiatric disorders in Puerto Rico
5. Panic and phobias
6. Epidemiology of mood disorders: A community survey in Florence
7. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule
8. Birth cohort trends in major depression: Increasing rates and earlier onset in New Zealand
9. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey
10. Lifetime and current comorbidity of anxiety and affective disorders: Results from the international WHO/ADAMHA CIDI field trials
11. Depression in the community: The first pan-European study, DEPRES (Depression Research in European Society)
12. The underrecogntion and undertreatment of depression: What is the breadth and depth of the problem?
13. An overview of psychiatric disorders in America
14. Treatment received by depressed patients
15. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
16. Adequacy and duration of antidepressant treatment in primary care
17. Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the medical outcomes study
18. A comparison of adequately vs. inadequately treated depressed patients
19. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: A prospective follow-up
20. DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community
21. Identification of depressed patient types in the community and their treatment needs: Findings from the DEPRES II (Depression Research in European Society II) survey
22. The economic consequences of not treating depression